RJS Biologics LLC is a biopharmaceutical company which, discovers, invents, develops, manufactures, and aspires to commercialize medicines for the treatment of serious unmet medical conditions in the United States and internationally. The company is currently in its preclinical phase and is actively seeking strategic collaborative partners to bring its therapeutic agents forward into the clinic. Our technology could be used to prevent catastrophic late stage developmental or clinical stage therapeutic failure of anti-cancer compounds. Please do not hesitate to contact us.
We currently conduct preclinical research programs in the areas of oncology, inflammation and immune diseases. The company was founded in 2009 and is headquartered in stunning Seattle, Washington.